Sysmex Corporation (SSMXY)
USD 18.76
(-0.27%)
USD 18.76
(-0.27%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 461.51 Billion JPY | 12.43% |
| 2023 | 410.5 Billion JPY | 12.84% |
| 2022 | 363.78 Billion JPY | 19.24% |
| 2021 | 305.07 Billion JPY | 1.02% |
| 2020 | 301.98 Billion JPY | 2.89% |
| 2019 | 293.5 Billion JPY | 4.1% |
| 2018 | 281.93 Billion JPY | 12.82% |
| 2017 | 249.89 Billion JPY | -1.08% |
| 2016 | 252.62 Billion JPY | 14.11% |
| 2015 | 221.37 Billion JPY | 19.96% |
| 2014 | 184.53 Billion JPY | 26.76% |
| 2013 | 145.57 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 95.35 Billion JPY | -14.68% |
| 2024 Q2 | 117.34 Billion JPY | 23.07% |
| 2024 Q3 | 113.82 Billion JPY | -3.0% |
| 2024 FY | 461.51 Billion JPY | 12.43% |
| 2024 Q4 | 134.98 Billion JPY | 18.59% |
| 2023 Q2 | 107.99 Billion JPY | 25.53% |
| 2023 FY | 410.5 Billion JPY | 12.84% |
| 2023 Q4 | 111.75 Billion JPY | 6.72% |
| 2023 Q3 | 104.72 Billion JPY | -3.03% |
| 2023 Q1 | 86.02 Billion JPY | -17.97% |
| 2022 Q3 | 90.14 Billion JPY | 0.85% |
| 2022 Q2 | 89.39 Billion JPY | 12.63% |
| 2022 FY | 363.78 Billion JPY | 19.24% |
| 2022 Q1 | 79.36 Billion JPY | -14.87% |
| 2022 Q4 | 104.87 Billion JPY | 16.34% |
| 2021 Q2 | 71.57 Billion JPY | 18.28% |
| 2021 FY | 305.07 Billion JPY | 1.02% |
| 2021 Q3 | 79.76 Billion JPY | 11.45% |
| 2021 Q1 | 60.51 Billion JPY | -27.81% |
| 2021 Q4 | 93.22 Billion JPY | 16.87% |
| 2020 Q4 | 83.81 Billion JPY | 11.5% |
| 2020 FY | 301.98 Billion JPY | 2.89% |
| 2020 Q3 | 75.17 Billion JPY | 0.97% |
| 2020 Q2 | 74.45 Billion JPY | 8.62% |
| 2020 Q1 | 68.54 Billion JPY | -19.49% |
| 2019 Q3 | 72.17 Billion JPY | 2.77% |
| 2019 FY | 293.5 Billion JPY | 4.1% |
| 2019 Q1 | 65.96 Billion JPY | -16.91% |
| 2019 Q2 | 70.23 Billion JPY | 6.48% |
| 2019 Q4 | 85.13 Billion JPY | 17.95% |
| 2018 Q3 | 71.44 Billion JPY | 2.96% |
| 2018 FY | 281.93 Billion JPY | 12.82% |
| 2018 Q1 | 61.71 Billion JPY | -10.69% |
| 2018 Q4 | 79.38 Billion JPY | 11.12% |
| 2018 Q2 | 69.38 Billion JPY | 12.43% |
| 2017 Q2 | 59.63 Billion JPY | 0.79% |
| 2017 Q3 | 61.99 Billion JPY | 3.96% |
| 2017 Q4 | 69.1 Billion JPY | 11.47% |
| 2017 FY | 249.89 Billion JPY | -1.08% |
| 2017 Q1 | 59.16 Billion JPY | -12.31% |
| 2016 FY | 252.62 Billion JPY | 14.11% |
| 2016 Q3 | 63.91 Billion JPY | -0.34% |
| 2016 Q2 | 64.13 Billion JPY | 11.26% |
| 2016 Q1 | 57.64 Billion JPY | -12.03% |
| 2016 Q4 | 67.47 Billion JPY | 5.57% |
| 2015 Q1 | 46.73 Billion JPY | -14.54% |
| 2015 Q4 | 65.52 Billion JPY | 15.5% |
| 2015 Q3 | 56.73 Billion JPY | 8.3% |
| 2015 Q2 | 52.38 Billion JPY | 12.08% |
| 2015 FY | 221.37 Billion JPY | 19.96% |
| 2014 Q2 | 44.53 Billion JPY | 12.61% |
| 2014 FY | 184.53 Billion JPY | 26.76% |
| 2014 Q4 | 54.68 Billion JPY | 19.49% |
| 2014 Q3 | 45.77 Billion JPY | 2.78% |
| 2014 Q1 | 39.54 Billion JPY | -10.52% |
| 2013 Q3 | 34.2 Billion JPY | -3.67% |
| 2013 Q2 | 35.5 Billion JPY | 0.0% |
| 2013 FY | 145.57 Billion JPY | 0.0% |
| 2013 Q4 | 44.19 Billion JPY | 29.21% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -14460616.271% |
| Ansell Limited | 1.61 Billion USD | -28400.587% |
| Ansell Limited | 1.61 Billion USD | -28400.587% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | -249841.127% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -341719939.984% |
| Psykey, Inc. | 419.29 Thousand USD | -110066940.465% |
| ConvaTec Group Plc | 2.19 Billion USD | -20934.946% |
| ConvaTec Group Plc | 2.14 Billion USD | -21441.729% |
| Encision Inc. | 6.58 Million USD | -7007465.577% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -25289158.463% |
| LifePoint, Inc. | -18.5 Thousand USD | 2494648748.649% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | -6773861.544% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -59780988.083% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -46795746.768% |
| Reflect Scientific, Inc. | 1.08 Million USD | -42726214.951% |
| SmileDirectClub, Inc. | 470.74 Million USD | -97938.633% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | -24558.462% |
| SheerVision, Inc. | 3.49 Million USD | -13188134.464% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -33290818.088% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -61939818.909% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -442555254.18% |